Investigating what level of visual information inspires trust in a user of a highly automated vehicle

The aim of this research is to investigate whether visual feedback alone can affect a driver’s trust in an autonomous vehicle, and in particular, what level of feedback (no feedback vs. moderate feedback vs. high feedback) will evoke the appropriate level of trust. Before conducting the experiment, the Human Machine Interfaces (HMI) were piloted with two sets of six participants (before and after iterations), to ensure the meaning of the displays can be understood by all. A static driving simulator experiment was conducted with a sample of 30 participants (between 18 and 55). Participants completed two pre-study questionnaires to evaluate previous driving experience, and attitude to trust in automation. During the study, participants completed a trust questionnaire after each simulated scenario to assess their trust level in the autonomous vehicle and HMI displays, and on intention to use and acceptance. The participants were shown 10 different driving scenarios that lasted approximately 2 minutes each. Results indicated that the ‘high visual feedback’ group recorded the highest trust ratings, with this difference significantly higher than for the ‘no visual feedback’ group (U = .000; p = <0.001 < α) and the ‘moderate visual feedback’ group (U = .000; p = <0.001 < α). There is an upward inclination of trust in all groups due to familiarity to both the interfaces and driving simulator over time. Participants’ trust level was also influenced by the driving scenario, with trust reducing in all displays during safety verses non-safety-critical situations

Dissociation by steroids of eosinophilic inflammation from airway hyperresponsiveness in murine airways

Background The link between eosinophils and the development of airway hyperresponsiveness (AHR) in asthma is still controversial. This question was assessed in a murine model of asthma in which we performed a dose ranging study to establish whether the dose of steroid needed to inhibit the eosinophil infiltration correlated with that needed to block AHR. Methods The sensitised BALB/c mice were dosed with vehicle or dexamethasone (0.01–3 mg/kg) 2 hours before and 6 hours after each challenge (once daily for 6 days) and 2 hours before AHR determination by whole-body plethysmography. At 30 minutes after the AHR to aerosolised methacholine the mice were lavaged and differential white cell counts were determined. Challenging with antigen caused a significant increase in eosinophils in the bronchoalveolar lavage (BAL) fluid and lung tissue, and increased AHR. Results Dexamethasone reduced BAL and lung tissue eosinophilia (ED50 values of 0.06 and 0.08 mg/kg, respectively), whereas a higher dose was needed to block AHR (ED50 of 0.32 mg/kg at 3 mg/ml methacholine. Dissociation was observed between the dose of steroid needed to affect AHR in comparison with eosinophilia and suggests that AHR is not a direct consequence of eosinophilia. Conclusion This novel pharmacological approach has revealed a clear dissociation between eosinophilia and AHR by using steroids that are the mainstay of asthma therapy. These data suggest that eosinophilia is not associated with AHR and questions the rationale that many pharmaceutical companies are adopting in developing low-molecular-mass compounds that target eosinophil activation/recruitment for the treatment of asthma

Scalar Quantum Field Theory in Disordered Media

A free massive scalar field in inhomogeneous random media is investigated. The coefficients of the Klein-Gordon equation are taken to be random functions of the spatial coordinates. The case of an annealed-like disordered medium, modeled by centered stationary and Gaussian processes, is analyzed. After performing the averages over the random functions, we obtain the two-point causal Green's function of the model up to one-loop. The disordered scalar quantum field theory becomes qualitatively similar to a $\lambda\phi^{4}$ self-interacting theory with a frequency-dependent coupling

Aprepitant for cough in lung cancer: a randomised placebo-controlled trial and mechanistic insights

RATIONALE: Effective cough treatments are a significant unmet need in lung cancer patients. Aprepitant is a licensed treatment for nausea and vomiting, which blocks substance P activation of Neurokinin 1 (NK-1) receptors, a mechanism also implicated in cough. OBJECTIVE: To assess aprepitant in lung cancer patients with cough and evaluate mechanisms in vagal nerve tissue. METHODS: Randomised double-blind crossover trial of lung cancer patients with bothersome cough. They received three days of aprepitant or matched placebo; following a three day wash out, patients crossed to the alternative treatment. The primary endpoint was awake cough frequency measured at screening and day 3 of each treatment; secondary endpoints included patient-reported outcomes. In vitro, the depolarization of isolated guinea pig and human vagus nerve sections in grease gap recording chambers, indicative of sensory nerve activation, was measured to evaluate mechanism. MEASUREMENTS AND MAIN RESULTS: Twenty lung cancer patients enrolled, mean age 66years (±7.7), 60% female, 80% non-small cell cancer, 50% advanced stage and 55% WHO performance status 1. Cough frequency improved with aprepitant, reducing by 22.2%(95%CI 2.8-37.7%) over placebo whilst awake (p=0.03), 30.3%(95%CI 12.7-44.3) over 24hours (p=0.002) and 59.8%(95%CI 15.1-86.0) during sleep (p=0.081). Patient-reported outcomes all significantly improved. Substance P depolarised both guinea pig and human vagus nerve. Aprepitant significantly inhibited substance P induced depolarisation by 78% in guinea pig (p=0.0145) and 94% in human vagus (p=0.0145). DISCUSSION: Substance P activation of NK-1 receptors appears to be an important mechanism driving cough in lung cancer, and NK-1 antagonists show promise as anti-tussive therapies. Clinical trial registration available at www.http://www.isrctn.com/, ID: ISRCTN16200035

Coarse-Graining and Renormalization Group in the Einstein Universe

The Kadanoff-Wilson renormalization group approach for a scalar self-interacting field theor generally coupled with gravity is presented. An average potential that monitors the fluctuations of the blocked field in different scaling regimes is constructed in a nonflat background and explicitly computed within the loop-expansion approximation for an Einstein universe. The curvature turns out to be dominant in setting the crossover scale from a double-peak and a symmetric distribution of the block variables. The evolution of all the coupling constants generated by the blocking procedure is examined: the renormalized trajectories agree with the standard perturbative results for the relevant vertices near the ultraviolet fixed point, but new effective interactions between gravity and matter are present. The flow of the conformal coupling constant is therefore analyzed in the improved scheme and the infrared fixed point is reached for arbitrary values of the renormalized parameters.Comment: 18 pages, REVTex, two uuencoded figures. (to appear in Phys. Rev. D15, July) Transmission errors have been correcte

On the weight of entanglement

We investigate a scenario where quantum correlations affect the gravitational field. We show that quantum correlations between particles occupying different positions have an effect on the gravitational field. We find that the small perturbations induced by the entanglement depend on the amount of entanglement and vanish for vanishing quantum correlations. Our results suggest that there is a form of entanglement that has a weight, since it affects the gravitational field. This conclusion may lead towards a new understanding of the role of quantum correlations within the overlap of relativistic and quantum theories.Comment: 6 pages, no figures. Updated to match published versio

Effective action in a higher-spin background

We consider a free massless scalar field coupled to an infinite tower of background higher-spin gauge fields via minimal coupling to the traceless conserved currents. The set of Abelian gauge transformations is deformed to the non-Abelian group of unitary operators acting on the scalar field. The gauge invariant effective action is computed perturbatively in the external fields. The structure of the various (divergent or finite) terms is determined. In particular, the quadratic part of the logarithmically divergent (or of the finite) term is expressed in terms of curvatures and related to conformal higher-spin gravity. The generalized higher-spin Weyl anomalies are also determined. The relation with the theory of interacting higher-spin gauge fields on anti de Sitter spacetime via the holographic correspondence is discussed.Comment: 40 pages, Some errors and typos corrected, Version published in JHE